The company is in a secular downtrend fundamentally, but the stock has risen with the market in this wild ride over the past 12 months.
Though the chip manufacturing giant is lower post-earnings, there's a lot to like about its revenue and capex guidance, as well as other commentary it shared.
This trade is essentially a stock replacement strategy.
Here's where aggressive traders could go long.
Here is where aggressive traders could go long the cancer therapy name.
Let's check out LOGI's charts and indicators and find out.
I keep saying own Apple, don't trade it. If not? I can't help you.
There's not a compelling bullish case at this point.
Let's review the charts and indicators.